DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic devices market is projected to register a CAGR of 4.2% ov…
Author: Business Wire
Insights on the Retinal Disorder Treatment Global Market to 2027 – Growing Strategic Collaborations and Commercialization of Novel Products Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Disorder Treatment Market Research Report by Type (Diabetic Retinopathy and Macular Degeneration), Dosage Form, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global F…
NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces record sales of Avenova-b…
The Worldwide Objective Lenses Industry is Projected to Reach $4.6 Billion by 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Objective Lenses Market (2022-2027) by Product Type, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering…
Kubota Vision Announces Publication in Scientific Reports; Effects of Using Projected Peripheral Myopic Defocus
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of a…
Eye Health America Announces Newest Acquisition of Bradenton Eye Clinic
BRADENTON, Fla.–(BUSINESS WIRE)–Eye Health America (EHA), an integrated platform of leading eyecare practices across the Southeastern United States, announced today a new partnership with Bradenton Eye Clinic, the company’s 21st partnership since 201…
Global Ophthalmic Ultrasound Systems Market Report 2022: 10 Largest Ophthalmic Ultrasound Systems Players Market Share by Revenue – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Ultrasound Systems Market Research Report 2022 (Status and Outlook)” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmic Ultrasound Systems market was estimated at USD 2564.7…
New Two-Year Data Confirm Genentech’s Vabysmo Improves Vision With Fewer Treatments for People With Wet Age-Related Macular Degeneration
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new two-year data from the TENAYA and LUCERNE studies that reinforce the long-term efficacy, safety and durability of Vab…
Verstärkung von AESARA Europe durch die Ernennung der Expertin für Marktzugang, Sameera Tak
CHAPEL HILL, North Carolina, USA & TORONTO, Kanada & LONDON, UK & ZUG, Schweiz–(BUSINESS WIRE)–AESARA (www.aesara.com) freut sich, die Aufnahme der erfahrenen Managerin für Marktzugang in der Industrie, Sameera Tak, MSc, in das europäische Team für s…
Samenvatting: Uitbreiding van AESARA Europe met de aanstelling van Market Access Expert, Sameera Tak
CHAPEL HILL, N.C. & TORONTO & LONDEN & ZUG, Zwitserland–(BUSINESS WIRE)–AESARA (www.aesara.com) is verheugd de benoeming aan te kondigen van ervaren Market Access Executive Sameera Tak, MSc, in het European Strategic Partnerships-team. Sameera sluit …
Expansion d’AESARA Europe grâce à la nomination de l’experte en accès au marché, Sameera Tak
CHAPEL HILL, Caroline du Nord, TORONTO, LONDRES, et ZOUG, Suisse–(BUSINESS WIRE)–AESARA (www.aesara.com) est ravie d’annoncer la nomination de la responsable expérimentée du secteur de l’accès au marché, Sameera Tak, titutaire d’un « Master of Scienc…
Riassunto: AESARA Europe espande il proprio organico con la nomina dell’esperta di accesso ai mercati Sameera Tak
CHAPEL HILL, Carolina del Nord, TORONTO, LONDRA e ZUGO, Svizzera–(BUSINESS WIRE)–AESARA (www.aesara.com) è lieta di annunciare la nomina della veterana del settore, esperta di accesso ai mercati, la dott.ssa Sameera Tak, alla direzione del team per l…
Resumen: Ampliación de AESARA Europa con el nombramiento de Sameera Tak, experta en acceso al mercado
CHAPEL HILL, Carolina del Norte, TORONTO, LONDRES Y ZUG, Suiza–(BUSINESS WIRE)–AESARA (www.aesara.com) se complace en anunciar la incorporación de la experimentada ejecutiva de acceso al mercado de la industria Sameera Tak, al equipo de Asociaciones …
Expansion of AESARA Europe with the Appointment of Market Access Expert, Sameera Tak
CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)– #Europe–AESARA (www.aesara.com) is pleased to announce the appointment of experienced industry market access executive Sameera Tak, MSc, to the European Strategic Partnerships …
Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release secon…
Global Smart Contact Lenses Market to Witness 9.8% CAGR During 2022-2027 – Leading Players are Sensimed, Mojo Vision, Innovega, InWith, and Johnson & Johnson – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smart Contact Lenses Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Smart Contact Lenses Market is expected to register a CAGR of…
WALDO Launches Industry-First Hydra Boost Plus Lenses in the United States
NEW YORK–(BUSINESS WIRE)–WALDO, the innovative eyecare brand, today announces the launch of their Hydra Boost Plus contact lenses, now available at hiwaldo.com. A completely new-to-the-U.S. product, these daily contact lenses are infused with a uniqu…
MyMD Pharmaceuticals to Collaborate with Bascom Palmer Eye Institute to Study MYMD-1 in Ophthalmic Conditions
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, announced today that it has en…
jCyte Announces Appointment of Dr. Stewart Craig as Chief Technology Officer
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the expansion of the company’s leadership team with the appointment of Dr. S…
Quantabio’s New qScript Ultra Product Family Builds on More Than 20 Years of RNA and DNA Enzyme Technology Innovation
BEVERLY, Mass.–(BUSINESS WIRE)– #EnzymeInnovation–Quantabio announced the commercial availability of the qScript Ultra Flex Kit and the qScript Ultra SuperMix for the synthesis of first-strand cDNA